The offering is aimed at institutional and other experienced investors.
A medical technology company Nanoform Finland announces its intention to issue shares to institutional and other experienced investors.
In the share issue, Nanoform will issue seven million new shares.
The proceeds from the offering will be used to implement Nanoform’s growth strategy and to commercialize and grow the company’s products.
The expedited process will begin immediately.